Jinxin Fertility Group Ltd is dedicated to providing reliable and innovative reproductive healthcare solutions. With a strong commitment to ethical practices, they prioritize patient safety and satisfaction. Jinxin Fertility Group Ltd's corporate philosophy revolves around promoting and advancing fertility treatments, ensuring accessibility and affordability for couples seeking infertility care. By combining cutting-edge technology with personalized care, they aim to achieve high success rates in assisted reproductive technology procedures. Jinxin Fertility Group Ltd values integrity, professionalism, and excellence in delivering comprehensive fertility services, fostering hope, and making dreams of starting a family come true.

Jinxin Fertility Group Ltd is primarily present in China.

Jinxin Fertility Group Ltd has achieved several significant milestones. Firstly, the company successfully listed on the Stock Exchange of Hong Kong in 2018, marking a major achievement in its growth trajectory. Additionally, Jinxin Fertility Group Ltd has expanded its presence by opening multiple fertility treatment centers across China, solidifying its position as a leading provider of reproductive health services in the country. The company has also achieved noteworthy advancements in technology and research, consistently introducing innovative techniques and treatments to enhance patient outcomes. With its commitment to excellence and continuous development, Jinxin Fertility Group Ltd has established itself as a prominent player in the fertility industry.

Jinxin Fertility Group Ltd is a leading company in the fertility industry. Established in XXXX, it has quickly gained prominence for its innovative fertility treatments and advanced technology. With a wide range of services including in-vitro fertilization (IVF), preimplantation genetic diagnosis (PGD), and reproductive surgery, Jinxin Fertility Group Ltd has successfully helped countless individuals and couples achieve their dream of parenthood. The company is known for its state-of-the-art facilities and highly skilled medical professionals who are dedicated to providing personalized care and support throughout the journey to conception. As a trusted name in the field, Jinxin Fertility Group Ltd continues to revolutionize the fertility industry and bring hope to those struggling with infertility.

The main competitors of Jinxin Fertility Group Ltd in the market include other prominent players in the fertility services industry, such as Hangzhou Tigermed Consulting Co., Ltd, New Hope Fertility Co., Ltd, and Merck KGaA. These competitors possess similar expertise in the field of assisted reproductive technology and offer comparable services to individuals and couples seeking fertility treatments. By constantly innovating and delivering high-quality fertility solutions, Jinxin Fertility Group Ltd strives to maintain a competitive edge in the market against these key rivals.

Jinxin Fertility Group Ltd is primarily active in the healthcare and fertility industry.

The business model of Jinxin Fertility Group Ltd revolves around providing comprehensive fertility services and solutions. Jinxin Fertility Group Ltd specializes in offering a wide range of assisted reproductive technology (ART) services, including in vitro fertilization (IVF), genetic testing, and fertility preservation. The company's goal is to assist individuals and couples in overcoming fertility challenges and achieving their dream of starting a family. Jinxin Fertility Group Ltd is committed to delivering high-quality, personalized care to its patients, supported by a team of experienced fertility specialists and state-of-the-art facilities. Its business model combines medical expertise, advanced technology, and compassionate care to meet the diverse needs of its clients.

P/E odnos Jinxin Fertility Group iznosi 18,15.

KUV kompanije Jinxin Fertility Group iznosi 2,57.

AlleAktien kvalitativni skor za Jinxin Fertility Group je 3/10.

očekivana Jinxin Fertility Group promet je 3,15 milijardi CNY.

Dobit očekivana Jinxin Fertility Group je 445,22 mil. CNY.

Jinxin Fertility Group Ltd is an internationally recognized clinic group specializing in reproductive medicine. With comprehensive medical expertise, the latest treatment technologies, and a respectful approach to patients' individual needs, Jinxin Fertility has become a leading service provider in this field. An important part of Jinxin Fertility Group's business model is to offer high-quality services and products that meet the needs of patients in different income groups. This includes a wide range of treatments and procedures, from basic consultations to complex invasive techniques such as in-vitro fertilization (IVF). In addition to fertility treatment, Jinxin Fertility Group also offers other services, including preventive healthcare, cosmetic gynecology, and medical tourism. Patients from around the world come to avail themselves of the services of Jinxin Fertility Group. There has been an increase in the number of patients, particularly from Asian countries such as Japan, Korea, Vietnam, and Thailand. But European and American patients are also increasingly choosing the group's services. The group has a very large network of internationally recognized specialists in the field of reproductive medicine. The doctors and medical staff are highly qualified and have extensive experience. They work with state-of-the-art technology and utilize the latest innovations in fertility treatment. Jinxin Fertility Group also offers special programs for couples experiencing difficulty in achieving pregnancy, such as the "Baby Now" program. This is a customized package of IVF treatment. The program includes comprehensive pre-examinations, individual treatment with cutting-edge technologies and medications, as well as continuous monitoring and a special care program. Another important component of Jinxin Fertility Group's business model is to continue developing new methods and treatments through medical progress and research to increase the chances of successful pregnancy. The group collaborates with leading research institutes and specialized institutions around the world. Overall, Jinxin Fertility Group is an established and successful clinic group with a comprehensive range of services and products in the field of reproductive medicine. The group is focused on a broad national and international customer portfolio and offers a comprehensive program of research, diagnostics, and treatment. Its goal is always to maximize the chances of pregnancy for each individual patient.

Jinxin Fertility Group isplaćuje dividendu od 0,07 CNY raspoređenu preko isplata u toku godine.

Dividenda za Jinxin Fertility Group trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Jinxin Fertility Group je KYG5140J1013.

WKN od Jinxin Fertility Group je A2PL6U.

Oznaka za praćenje akcija kompanije Jinxin Fertility Group je 1951.HK.

U poslednjih 12 meseci, Jinxin Fertility Group je isplatio dividendu u iznosu od 0,07 CNY . To odgovara dividendnom prinosu od oko 2,50 %. Za narednih 12 meseci, Jinxin Fertility Group će verovatno isplatiti dividendu od 0,24 CNY.

Dividendski prinos od Jinxin Fertility Group trenutno iznosi 2,50 %.

Jinxin Fertility Group isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima август, јул, јул, август.

Jinxin Fertility Group je isplaćivao dividendu svake godine u poslednjih 0 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0,24 CNY. To odgovara dividendnom prinosu od 8,02 %.

Jinxin Fertility Group se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Jinxin Fertility Group od 25. 7. 2024. u iznosu od 0,01 CNY, morali ste da imate akciju u depou pre Ex-dana 1. 7. 2024..

Isplata poslednje dividende izvršena je 25. 7. 2024..

U godini 2023 kompanija Jinxin Fertility Group je isplatila 0,074 CNY kao dividende.

Dividende od Jinxin Fertility Group se isplaćuju u CNY.